LN-288832
Zofluza intermediate , NLT 98% , 1370250-39-7
CAS NO.:1370250-39-7
Empirical Formula: C17H17N3O4
Molecular Weight: 327.33
MDL number: MFCD31706264
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 575.3±60.0 °C(Predicted) |
| Density | 1.43±0.1 g/cm3(Predicted) |
| storage temp. | Refrigerator |
| pka | -1.40±0.40(Predicted) |
| form | Solid |
| Appearance | Yellow to brown Solid |
| InChI | InChI=1S/C17H17N3O4/c21-13-6-7-20-15(16(13)24-10-12-4-2-1-3-5-12)17(22)19-8-9-23-11-14(19)18-20/h1-7,14,18H,8-11H2 |
| InChIKey | HJTRSKVIYMCKJU-UHFFFAOYSA-N |
| SMILES | N12C=CC(=O)C(OCC3=CC=CC=C3)=C1C(=O)N1CCOCC1N2 |
Description and Uses
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione is an intermediate of the antiviral drug baloxavir, which is used in the treatment of influenza A and B. It is used as an intermediate in the synthesis and manufacture of pharmaceuticals. It can be used as organic synthesis and pharmaceutical intermediates, mainly used in laboratory research and development and chemical production process of API synthesis research.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |




![7,8-difluorodibenzo[b,e]thiepin-11(6H)-one](https://img.chemicalbook.com/CAS/20200611/GIF/2136287-66-4.gif)


![(R)-7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione](https://img.chemicalbook.com/CAS/20200611/GIF/1985607-70-2.gif)